CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM-2017 EXECUTIVE SUMMARY

被引：313

作者：

Garber, Alan J. ^{[1
,2
,3
]}

Abrahamson, Martin J. ^{[4
,5
]}

Barzilay, Joshua I. ^{[6
,7
]}

Blonde, Lawrence ^{[8
]}

Bloomgarden, Zachary T. ^{[9
]}

Bush, Michael A. ^{[10
,11
]}

Dagogo-Jack, Samuel ^{[12
]}

DeFronzo, Ralph A. ^{[13
,14
]}

Einhorn, Daniel ^{[15
,16
,17
,18
]}

Fonseca, Vivian A. ^{[19
,20
,21
]}

Garber, Jeffrey R. ^{[22
]}

Garvey, W. Timothy ^{[23
,24
]}

Grunberger, George ^{[25
,26
,27
,28
,29
]}

Handelsman, Yehuda ^{[30
,31
]}

Hirsch, Irl B. ^{[32
]}

Jellinger, Paul S. ^{[33
,34
]}

McGill, Janet B. ^{[35
]}

Mechanick, Jeffrey I. ^{[36
,37
]}

Rosenblit, Paul D. ^{[38
,39
,40
]}

Umpierrez, Guillermo E. ^{[41
,42
]}

机构：

[1] Baylor Coll Med, Dept Med, Houston, TX 77030 USA

[2] Baylor Coll Med, Dept Med Biochem & Mol Biol, Houston, TX 77030 USA

[3] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA

[4] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA

[5] Harvard Med Sch, Boston, MA 02215 USA

[6] Kaiser Permanente Georgia, Div Endocrinol, Atlanta, GA USA

[7] Emory Univ, Sch Med, Div Endocrinol, Atlanta, GA USA

[8] Ochsner Med Ctr, Dept Endocrinol, Frank Riddick Diabet Inst, Ochsner Diabet Clin Res Unit, New Orleans, LA USA

[9] Mt Sinai Sch Med, New York, NY USA

[10] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Div Endocrinol, Los Angeles, CA 90048 USA

[11] Univ Calif Los Angeles, Geffen Sch Med, Med, Los Angeles, CA USA

[12] Univ Tennessee, Ctr Hlth Sci, Div Endocrinol Diabet & Metab, Memphis, TN 38163 USA

[13] Univ Texas Hlth Sci Ctr San Antonio, Med, San Antonio, TX 78229 USA

[14] Univ Texas Hlth Sci Ctr San Antonio, Diabet Div, San Antonio, TX 78229 USA

[15] Amer Coll Endocrinol, La Jolla, CA USA

[16] Amer Assoc Clin Endocrinologists, La Jolla, CA USA

[17] UCSD, Scripps Whittier Diabet Inst, La Jolla, CA USA

[18] UCSD, Med, La Jolla, CA USA

[19] Tulane Univ, Hlth Sci Ctr, Med & Pharmacol, New Orleans, LA 70118 USA

[20] Tulane Univ, Hlth Sci Ctr, Diabet, New Orleans, LA 70118 USA

[21] Tulane Univ, Hlth Sci Ctr, Endocrinol Sect, New Orleans, LA 70118 USA

[22] Beth Israel Deaconess Med Ctr, Endocrine Div, Harvard Vanguard Med Associates, Div Endocrinol, Boston, MA 02215 USA

[23] Univ Alabama Birmingham, Dept Nutr Sci, Mt Brook, AL USA

[24] UAB Diabet Res Ctr, Mt Brook, AL USA

[25] Wayne State Univ, Sch Med, Grunberger Diabet Inst, Detroit, MI 48202 USA

[26] Wayne State Univ, Sch Med, Internal Med & Mol Med & Genet, Detroit, MI 48202 USA

[27] Oakland Univ, William Beaumont Sch Med, Internal Med, Rochester, MI USA

[28] Amer Assoc Clin Endocrinologists, 245 Riverside Ave,Suite 200, Jacksonville, FL 32202 USA

[29] Amer Coll Endocrinol, Jacksonville, FL USA

[30] Metab Inst Amer, Tarzana, CA USA

[31] AACE Diabet Sci Comm, Tarzana, CA USA

[32] Univ Washington, Sch Med, Med, Seattle, WA USA

[33] Univ Miami, Miller Sch Med, Med Clin, Miami, FL 33136 USA

[34] Ctr Diabet & Endocrine Care, Hollywood, FL USA

[35] Washington Univ, Div Endocrinol Metab & Lipid Res, Med, St Louis, MO USA

[36] Icahn Sch Med Mt Sinai, Med, New York, NY 10029 USA

[37] Icahn Sch Med Mt Sinai, Metab Support, Div Endocrinol Diabet & Bone Dis, New York, NY 10029 USA

[38] Univ Calif Irvine, Sch Med, Div Endocrinol, Med,Diabet,Metab, Irvine, CA 92717 USA

[39] UCI Med Ctr, Outpatient Clin, Orange, CA USA

[40] Diabetes Lipid Management & Res Ctr, Huntington Beach, CA USA

[41] Emory Univ, Sch Med, Med, Atlanta, GA USA

[42] Grady Hlth Syst, Endocrinol Sect, Atlanta, GA USA

来源：

ENDOCRINE PRACTICE | 2017年 / 23卷 / 02期

关键词：

CORONARY-HEART-DISEASE; TO-TARGET TRIAL; RANDOMIZED CONTROLLED-TRIAL; CONTROLLED-RELEASE PHENTERMINE/TOPIRAMATE; DENSITY-LIPOPROTEIN CHOLESTEROL; IMPAIRED GLUCOSE-TOLERANCE; COMBINATION LIPID THERAPY; TERM DIETARY INTERVENTION; IMPROVES GLYCEMIC CONTROL; PLACEBO-CONTROLLED TRIAL;

D O I：

10.4158/EP161682.CS

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This document represents the official position of the American Association of Clinical Endocrinologists and American College of Endocrinology. Where there were no randomized controlled trials or specific U.S. FDA labeling for issues in clinical practice, the participating clinical experts utilized their judgment and experience. Every effort was made to achieve consensus among the committee members. Position statements are meant to provide guidance, but they are not to be considered prescriptive for any individual patient and cannot replace the judgment of a clinician.

引用

页码：207 / 238

页数：32

共 250 条

[71] Diabetes Prevention Progam, 2005, DIABETES, V54, P1150
[72] Ditschuneit HH, 1999, AM J CLIN NUTR, V69, P198
[73] Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
Dormandy, JA
Charbonnel, B
Eckland, DJA
Erdmann, E
Massi-Benedetti, M
Kmoules, IK
Skene, AM
Tan, MH
Lefébvre, PJ
Murray, GD
Standl, E
Wilcox, RG
Wlhelmsen, L
Betteridge, J
Birkeland, K
Golay, A
Heine, RJ
Korányi, L
Laakso, M
Mokán, M
Norkus, A
Pirags, V
Podar, T
Scheen, A
Scherbaum, W
Schernthaner, G
Schmitz, O
Skrha, J
Smith, U
Taton, J
[J]. LANCET, 2005, 366 (9493) : 1279 - 1289
[74] Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
Duckworth, William
Abraira, Carlos
Moritz, Thomas
Reda, Domenic
Emanuele, Nicholas
Reaven, Peter D.
Zieve, Franklin J.
Marks, Jennifer
Davis, Stephen N.
Hayward, Rodney
Warren, Stuart R.
Goldman, Steven
McCarren, Madeline
Vitek, Mary Ellen
Henderson, William G.
Huang, Grant D.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (02) : 129 - U62
[75] Espeland M, 2007, DIABETES CARE, V30, P1374
[76] Evert AB, 2013, DIABETES CARE, V36, P3821, DOI [10.2337/dc14-S120, 10.2337/dc13-2042]
[77] Pioglitazone and risk of bladder cancer: a meta-analysis of controlled studies
Ferwana, M.
Firwana, B.
Hasan, R.
Al-Mallah, M. H.
Kim, S.
Montori, V. M.
Murad, M. H.
[J]. DIABETIC MEDICINE, 2013, 30 (09) : 1026 - 1032
[78] A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial
Fidler, Meredith C.
Sanchez, Matilde
Raether, Brian
Weissman, Neil J.
Smith, Steven R.
Shanahan, William R.
Anderson, Christen M.
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (10) : 3067 - 3077
[79] Metabolic and weight loss effects of long-term dietary intervention in obese patients: Four-year results
Flechtner-Mors, M
Ditschuneit, HH
Johnson, TD
Suchard, MA
Adler, G
[J]. OBESITY RESEARCH, 2000, 8 (05): : 399 - 402
[80] Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence
Fonseca, Vivian A.
Handelsman, Yehuda
Staels, Bart
[J]. DIABETES OBESITY & METABOLISM, 2010, 12 (05) : 384 - 392

← 3 4 5 6 7 8 9 10 11 12 →